Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × tipifarnib × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1

Interventions

Specimen Handling 187 pembrolizumab 165 Magnetic Resonance Spectroscopy 147 Biopsy 112 Carboplatin 105 Cisplatin 89 Cyclophosphamide 85 Paclitaxel 72 Bevacizumab 65 Gemcitabine 64 venetoclax 63 Nivolumab 58 Radiotherapy 54 Dexamethasone 52 fludarabine 49 Pemetrexed 45 Rituximab 43 Oxaliplatin 43 Fluorouracil 39 Docetaxel 37 atezolizumab 36 Capecitabine 35 durvalumab 33 Cetuximab 33 X-Rays 31 Radiation 31 Leucovorin 31 Doxorubicin 31 Azacitidine 31 Lenalidomide 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06540963 2026-03-02

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

Milton S. Hershey Medical Center

Phase 2 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡